Berberine for diarrhea in children and adults: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Diarrhea is a ubiquitous digestive system disease, leading to loss of fluid and electrolytes, and may be life-threatening, especially in children and adults who are immunosuppressed or malnourished. Berberine has a broad-spectrum antibiotic activity and is very widely used to treat diarrhea in China. No systematic review has been carried out to evaluate the evidence presented in clinical trials. The aim of this study was to assess the effectiveness and safety of berberine in diarrhea treatment among children and adults. Methods: Seven databases and two clinical trial registries were searched on 1 September 2019. Randomized controlled trials were included, where participants were diagnosed (first diagnosed) as having diarrhea according to clear diagnostic criteria. Berberine alone or in combination with Western medication as intervention were included. Subgroup analyses were conducted based on children or adults, acute or persistent diarrhea, infectious or noninfectious and treatment courses. Primary outcomes were clinical cure rate and duration of diarrhea. The GRADE tool was used to assess the quality of evidence. Results: A total of 38 randomized controlled trials were included involving 3948 participants (including 27 trials on 2702 children) were included. Compared with antibiotics, berberine plus antibiotics showed better results in both adults and in children in general, especially when given for 7 days or 3 days in acute infectious diarrhea of children. Compared with the control groups, using berberine alone or in combination with montmorillonite, probiotics, and vitamin B increased the clinical cure rate of diarrhea. The use of berberine alone or berberine combined with montmorillonite reduced the duration of hospitalization. Using berberine had significantly better laboratory indicators (isoenzyme, inflammatory factors, myocardial enzyme, and fecal trait) and fewer systemic symptoms than the no berberine groups. Overall, 22 of 27 trials on children used berberine as an enema. No deaths and serious adverse events were reported. The quality of evidence of included trials was moderate to low or very low. The impact of different dosages, frequencies and treatment durations on the outcomes was not evaluated due to insufficient number of trials. Conclusion: This review demonstrated that berberine was generally effective in improving clinical cure rates and shortening the duration of diarrhea compared with control groups. No severe adverse event was reported. However, there is still a lack of high-quality evidence for evaluating the efficacy and safety of berberine. Trial registration: PROSPERO CRD42020151001 (available from http://www.crd.york.ac.uk/PROSPERO/ ).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea
Lukacik, M., Thomas, R. L., & Aranda, J. V. (2008) · Pediatrics · doi:10.1542/peds.2007-0921 · Cited by 188
Research works printed but not linked: 61
- Das JK, 2018, Cochrane Database Syst Rev, 12
- 10.1097/MCG.0b013e31826df662 · DOI · Paper page
- Pérez-Gaxiola G, 2018, Cochrane Database Syst Rev, 4
- Allen SJ, 2010, Cochrane Database Syst Rev, 2010
- 10.1002/14651858.CD005436.pub5 · DOI · Paper page
- MacGillivray S, 2013, Cochrane Database Syst Rev, 2013
- Qingwei Y, 2018, Psychological Monthly, 10
- 10.1002/ptr.5693 · DOI · Paper page
- Xiao PG, 2016, Mod Chin Med, 18, 1381
- 10.1136/bmj.291.6509.1601 · doi:10.1136/bmj.291.6509.1601
- 10.1142/S0192415X14500669 · DOI · Paper page
- Ukita T, 1949, Jpn J Exp Med, 20, 103
- 10.1139/m69-190 · DOI · Paper page
- 10.3109/13880209.2010.500295 · doi:10.3109/13880209.2010.500295
- 10.1093/infdis/155.5.979 · DOI · Paper page
- 10.18388/abp.2017_1621 · DOI
- Chen ZY, 1959, J Nanjing Med Univ (Natural Sciences), 233
- Shi RY, 1959, J Peking Univ (Health Sciences), 153
- 10.1007/BF02818693 · DOI · Paper page
- 10.1002/ptr.4926 · DOI
- Yang CZ, 2017, Clin Med, 37, 111
- Li W, 2017, Everybody Health (First Ten Day Edition), 11, 154
- Lin RX, 2016, J Colorectal Anal Surg, 22, 658
- Wei H, 2016, Med Front, 6, 358
- Wang ZH, 2016, Modern Digestion and Interventional Diagnosis and Treatment, 21, 323
- Chen H, 2015, Chin J Biochem Pharmaceuticals, 35, 97
- Luo YM, 2014, Clin Res Tradit Chin Med, 6, 110
- Ye J, 2013, Chin Med Innov, 10, 51
- Zhou Y, 2013, China Health Nutr, 614
- Huang YC, 2012, Asia Pac Tradit Med, 8, 137
- Fu JQ, 2011, Mod J Integr Tradit Chin West Med, 20, 3567
- Huang H, 2010, Chin Community Doct, 12, 84
- Li YL, 2010, Nurs Pract Res, 7, 33
- Hu YX, 2009, Chin Med Front, 4, 43
- Zhao L, 2007, World Health Dig, 4, 46
- Xu YF, 2006, J Qiqihar Med Coll, 1751
- Zhang HF, 2015, Health Care Today, 75
- Dang GL, 2011, Journal of Yan’an University (Medical Science Edition), 9, 52
- Wu J, 2001, China J New Drugs Clin Med, 360
- Liu H, 2015, Diet Health, 2, 49
- Wang YX, 2013, J Front Med, 5, 122
- Jin XH, 2012, Chinese Medical Guide, 10, 268
- Huang HH, 2011, Chin Pediatr Integr Tradit West Med, 3, 149
- Qiu LL, 2010, Chin J Mod Drug Appl, 4, 79
- Qin HL, 2010, Chinese and Foreign Medical Research, 8, 32
- Gan YL, 2009, Chin J Mod Nurse, 15, 51
- Guo XH, 2009, Chin J Mod Drug Appl, 3, 137
- Wang HQ, 2009, Chinese Journal of Misdiagnostics, 9, 7852
- Zhu HL, 2009, Zhejiang Prev Med, 21, 65
- Shi ZL, 2008, China Med Herald, 5, 66
- Wan YL, 2007, J Mod Med Health, 23
- Liu H, 2015, Diet Health, 2, 49
- Li H, 2004, J Nurs Sci, 58
- Geng Y, 2012, China Med Pharm, 2, 76
- Lu M, 2008, Chinese and Foreign Health Abstracts, Clinician Edition, 5, 87
- Yi Q, 2008, China Mod Doct, 46, 89
- Han ZZ, 2013, Inner Mongolia Med J, 45, 591
- Kang H, 2005, Med Theory Pract, 18, 1193
- Song SY, 1999, Chin J Microecology, 4, 70
- National Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Beijing: China Medical Science and Technology Press, 2015, pp.1243–1244.
- 10.1016/j.micpath.2015.11.027 · DOI
Cited by
Zhao, J. V., Yeung, W.-F., Chan, Y.-H., Vackova, D., Leung, J. Y. Y., Ip, D. K. M., Zhao, J., Ho, W.-K., Tse, H.-F., & Schooling, C. M. (2021) · Nutrients · doi:10.3390/nu13082550 · Cited by 58
“Systematic reviews and meta-analyses of clinical trials have shown a lipid-lowering effect of berberine in people with hyperlipidemia with or without coronary heart disease or diabetes [5,6,24], as well as potential benefits on blood pressure and adiposity [8,25,26], with no serious adverse events [5,6,8,27].”
BackgroundResultMing, J., Yu, X., Xu, X., Wang, L., Ding, C., Wang, Z., Xie, X., Li, S., Yang, W., Luo, S., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00942-7 · Cited by 52
“Berberine is a major constituent of traditional Chinese medicine, Coptis chinensis, which is usually used as an antibiotic to treat diarrhea [5].”
BackgroundSelf-citationDumitru, C. N., Marcu, T., Dumitru, A. O., Tudor, S. S., Ferțu, I. D., Elisei, A.-M., & Goroftei, L. (2026) · Pharmaceuticals · doi:10.3390/ph19081313 · Cited by 2
“The toxicity of berberine and related alkaloids also depends on dose and formulation [33,111], and the gastrointestinal safety profile is documented in dedicated syntheses [112].”
Metadata
- Authors
- Yu, M., Jin, X., Liang, C., Bu, F., Pan, D., He, Q., Ming, Y., Little, P., Du, H., Liang, S., Hu, R., Li, C., Hu, Y. J., Cao, H., Liu, J., & Fei, Y.
- Venue
- Therapeutic Advances in Gastroenterology
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 13
- Pages
- 1756284820961299-1756284820961299
- ISSN
- 1756-283X (ISSN-L)
- 1756-2848
- OpenAlex
- W3094596778
- Cited by
- 54
- References
- 2
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- national key research and development program of china stem cell and translational research (No. 2018YFE0102300)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Berberine for diarrhea in children and adults: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1177/1756284820961299
- The paper
- Yu, M., Jin, X., Liang, C., Bu, F., Pan, D., He, Q., Ming, Y., Little, P., Du, H., Liang, S., Hu, R., Li, C., Hu, Y. J., Cao, H., Liu, J., & Fei, Y. (2020). Berberine for diarrhea in children and adults: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756284820961299
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.